Senores Pharmaceuticals consolidated net profit rises 55.70% in the June 2026 quarter

Sales rise 38.30% to Rs 180.21 crore

Net profit of Senores Pharmaceuticals rose 55.70% to Rs 30.72 crore in the quarter ended June 2026 as against Rs 19.73 crore during the previous quarter ended June 2025. Sales rose 38.30% to Rs 180.21 crore in the quarter ended June 2026 as against Rs 130.30 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	180.21	130.30	38
OPM %	29.83	26.22	-
PBDT	49.40	32.48	52
PBT	39.46	26.49	49
NP	30.72	19.73	56

Powered by Capital Market - Live News